ContractConvertible Note Agreement • January 12th, 2017 • Co-Diagnostics, Inc. • Surgical & medical instruments & apparatus • Utah
THIS NOTE AND THE SHARES ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT.
EXCLUSIVE LICENSE AGREEMENT CO-DIAGNOSTICS, INC. LICENSOR WATERMARK GROUP INC. LICENSEEExclusive License Agreement • January 12th, 2017 • Co-Diagnostics, Inc. • Surgical & medical instruments & apparatus • Utah
This Agreement, effective October 13, 2016, is entered into between Co-Diagnostics, Inc. a Utah corporation, with its principal place of business located at 8160 S. Highland Drive, Sandy, Utah 84093 (referred to in this Agreement as "LICENSOR") and Watermark Group Inc., a Nevada corporation, with its principal place of business located at 64 Industrial Road, Richmond Hill, Ontario L4C 2Y1 (referred to in this Agreement as "LICENSEE").
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 12th, 2017 • Co-Diagnostics, Inc. • Surgical & medical instruments & apparatus • New York
THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”) is made as of December 12, 2016, by and among CO-DIAGNOSTICS, INC., a Utah corporation (and together with all of its current and future, direct and/or indirect, wholly owned and/or partially owned Subsidiaries, collectively, the “Company”), each purchaser identified on the signature pages hereto (the “Purchasers” and each a “Purchaser”).
EXCLUSIVE LICENSE AGREEMENT BETWEEN CO-DIAGNOSTICS, INC. AND DNA LOGIX, INC. COOPERATIVE PRIMERS APRIL 18, 2014 EXCLUSIVE LICENSE AGREEMENT BETWEEN CO- DIAGNOSTICS, INC. AND DNA LOGIX, INC. EXCLUSIVE LICENSE AGREEMENT BETWEENExclusive License Agreement • January 12th, 2017 • Co-Diagnostics, Inc. • Surgical & medical instruments & apparatus • Utah
This Agreement, effective ____________, 2014, is entered into between Co-Diagnostics, Inc. a Utah corporation, with its principal place of business located at 8160 S. Highland Drive, Sandy, Utah 84093 (referred to in this Agreement as "LICENSEE") and DNA Logix, Inc., a Utah corporation, with its principal place of business located at 585 West 500 South, #210, Bountiful, Utah 84010 (referred to in this Agreement as "LICENSOR").
ContractSubscription Agreement • January 12th, 2017 • Co-Diagnostics, Inc. • Surgical & medical instruments & apparatus • Utah
THE SECURITIES THAT ARE THE SUBJECT OF THIS AGREEMENT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER THE SECURITIES LAWS OF ANY STATE OR FOREIGN JURISDICTION AND WILL BE OFFERED AND SOLD IN RELIANCE ON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF THOSE LAWS BY VIRTUE OF THE COMPANY’S (AS DEFINED BELOW) INTENDED COMPLIANCE WITH SECTION 4(2) OF THE SECURITIES ACT OF 1933, AS AMENDED, THE PROVISIONS OF REGULATION D UNDER SUCH ACT, THE PROVISIONS OF REGULATION S UNDER SUCH ACT AND SIMILAR EXEMPTIONS UNDER STATE LAW. THE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY ANY REGULATORY AUTHORITY. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
ContractSubscription Agreement • January 12th, 2017 • Co-Diagnostics, Inc. • Surgical & medical instruments & apparatus
THE SECURITIES THAT ARE THE SUBJECT OF THIS AGREEMENT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER THE SECURITIES LAWS OF ANY STATE OR FOREIGN JURISDICTION AND WILL BE OFFERED AND SOLD IN RELIANCE ON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF THOSE LAWS BY VIRTUE OF THE COMPANY’S (AS DEFINED BELOW) INTENDED COMPLIANCE WITH SECTION 4(2) OF THE SECURITIES ACT OF 1933, AS AMENDED, THE PROVISIONS OF REGULATION D UNDER SUCH ACT, THE PROVISIONS OF REGULATION S UNDER SUCH ACT AND SIMILAR EXEMPTIONS UNDER STATE LAW. THE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY ANY REGULATORY AUTHORITY. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
STOCK EXCHANGE AGREEMENT Among CO-DIAGNOSTICS, INC. and DNA LOGIX, INC. and THE SHAREHOLDERS OF DNA LOGIX, INC.Stock Exchange Agreement • January 12th, 2017 • Co-Diagnostics, Inc. • Surgical & medical instruments & apparatus • Utah
THIS STOCK EXCHANGE AGREEMENT (hereinafter referred to as this "Agreement"), is entered into effective as of the 22nd day of January, 2015 by and among CO-DIAGNOSTICS, INC., a Utah corporation (hereinafter referred to as " CDI"), DNA LOGIX, INC. a Delaware corporation (hereinafter referred to as “LOGIX”), and the shareholders of LOGIX (hereinafter referred to as the "Shareholders"), upon the following premises:
